Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
πΌ
SK
or Search
SIGN UP
SIGN IN
ENTITY
Neuren Pharmaceuticals (NEU AU)
Watchlist
74
Analysis
Health Care
β’
Australia
Neuren Pharmaceuticals Ltd. is a biopharmaceutical company. The Company researches neurological and metabolic disorders.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
β’
Neuren Pharmaceuticals
β’
21 Mar 2023 18:04
Quiddity Leaderboard-βββββββββββASX Jun 23: OZ Minerals Replacements and Other Changes
Seven Group Holdings (SVW AU) or Chorus Ltd (CNU NZ) could replace OZL in ASX 100 and Bellevue Gold (BGL AU) or Neuren Pharmaceuticals (NEU AU)...
Janaghan Jeyakumar, CFA
Follow
532 Views
Share
bullish
β’
PolyNovo Ltd
β’
15 Mar 2023 07:03
Australia: S&P/βASX, REMX, GDXJ, MVA, MVW, Other Flows on Friday
Implementation of the S&P/ASX, REMX, GDXJ, MVA and other indices take place at the close on Friday. There will be a lot of passive flow going...
Brian Freitas
Follow
636 Views
Share
bullish
β’
Bellevue Gold
β’
06 Mar 2023 04:18
OZ Minerals (OZL AU): Scheme Meeting in April; Potential S&P/ASX Changes
OZL's acquisition by BHP is nearly a done deal. Passive trackers will sell 18.24m shs (A$509m; 9.6x ADV) of OZL on the last trading day. There will...
Brian Freitas
Follow
647 Views
Share
bullish
β’
Neuren Pharmaceuticals
β’
09 Sep 2022 08:00
β’
Issuer-paid
Neuren Pharmaceuticals Ltd - On the Cusp of Commercialisation
Neuren Pharmaceuticals Ltd On the cusp of commercialisation Neuren Pharmaceuticals Ltd (ASX:NEU) is a clinical-stage drug company focused...
Research as a Service (RaaS)
Follow
710 Views
Share
bullish
β’
Charter Hall Social Infrastructure REIT
β’
04 Sep 2022 22:04
S&P ASX Sep 22 Rebal: Decent Impacts but Avoid Short Buildup
The Top 10 ADDs & DELs have average impacts of +12.7 and -11.2 days to trade respectively. Some DELs names have significant short buildup.
Janaghan Jeyakumar, CFA
Follow
550 Views
Share
First
Previous
11
12
13
14
15
Next
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright Β© 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x